Vantage logo

A radical strategy for Medtronic

The sellside expects the world’s leading medtech to be outpaced by its rivals. Divestments might allow the group to defy this destiny.

Vantage logo

Covid-19 divides the biggest medtechs

Success or failure on the stock markets this year depended almost entirely on whether a company’s devices could be used to treat coronavirus patients.

Vantage logo

Collaborative diabetes tech on the Horizon

For diabetes devices interoperability is key, and partnerships between Insulet, Dexcom and Abbott show that rival groups see the benefits of working together.